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Abstract
Background: Mitochondria (mt) are highly susceptible to reactive oxygen species (ROS). In this
study, we investigated the association between a region within the displacement loop (D-loop) in
mtDNA that is highly susceptible to ROS and oxidative stress markers in chronic dialysis patients.
We enrolled 184 chronic dialysis patients and 213 age-matched healthy subjects for comparison.
Blood levels of oxidative stress markers, such as thiobarbituric acid reactive substances (TBARS)
and free thiol, and the mtDNA copy number were determined. A mononucleotide repeat sequence
(CCCC...CCCTCCCCCC) between nucleotides 303 and 316-318 (D310) was identified in
mtDNA.
Results: Depending on alterations in the D310 mononucleotide repeat, subjects were categorized
into 4 subgroups: 7-C, 8-C, 9 or 10-C, and T-to-C transition. Oxidative stress was higher in chronic
dialysis patients, evidenced by higher levels of TBARS and mtDNA copy number, and a lower level
of free thiol. The distribution of 7-C, 8-C, and 9-10C in dialysis and control subjects was as follows:
7-C (38% vs. 31.5%), 8-C (35.3% vs. 43.2%), and 9-10C (24.5% vs. 22.1%). Although there were
significant differences in levels of TBARS, free thiol, and the mtDNA copy number in the D310
repeat subgroups (except T-to-C transition) between dialysis patients and control subjects, post
hoc analyses within the same study cohort revealed no significant differences.
Conclusion: Although oxidative stress was elevated in chronic dialysis patients and resulted in a
compensatory increase in the mtDNA copy number, homopolymeric C repeats in the mtDNA
region (D310), susceptible to ROS, were not associated with oxidative stress markers in these
patients.
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Background
Chronic kidney disease (CKD) is characterized by a state
of increased oxidative stress [1]. This has been evidenced
by changes in oxidative stress biomarkers in the blood and
in tissue DNA. In our previous study, we demonstrated
that, in continuous ambulatory peritoneal dialysis
(CAPD) patients, the level of oxidative stress biomarkers
in the blood was elevated, with an accompanying increase
in the copy number of mitochondrial (mt) DNA [2].
mtDNA is a 16.6-kb double-stranded closed-circular DNA
molecule. In humans, the mutation rate of mtDNA is at
least 10 times higher than that of nuclear DNA. Most
mutations in mtDNA accumulate in the displacement
loop (D-loop) region. The D-loop functions as a promoter
for both heavy and light strands of mtDNA and does not
encode any functional proteins. A mononucleotide repeat
sequence (CCCC...CCCTCCCCCC) between nucleotides
303 and 316-318 of mtDNA has been reported to be a
hotspot of deletion or insertion mutation in primary
tumors [3-5]. D310 has been indicated to this region, a
term previously assigned by other investigators [6]. The
first stretch of cytosine bases is highly polymorphic, rang-
ing from 7-C and 9-C; 7-C is the most common sequence.
The D310 repeat is a part of conserved sequence block II
(CSBII), located 92 bp from the heavy-strand replication
region, and mtDNA replication is initiated when CSBII
forms a persistent RNA-DNA hybrid with CSBI and CSBIII
regions [7].
Nucleotide sequence analysis revealed that only a
homopolymeric sequence in CSBII, ranging from 6 to 12
residues in length, showed variability. In vitro transcrip-
tional analyses have revealed that most common poly-
mers could support accurate transcriptional initiation [8].
Because the D-loop region is a susceptible region for oxi-
dative stress, we hypothesized that the D-loop mutation
exists in dialysis patients with an increased oxidative stress
status. In this study, we investigated that hypothesis via
measurement of the D310 repeat in dialysis patients.
Methods
As study subjects, we enrolled those patients who visited
our outpatient department between December 2004 and
July 2005. Dialysis patients were considered eligible if
they had been receiving CAPD and hemodialysis (HD) for
more than 3 months; showed no evidence of chronic or
acute infections, inflammatory disorders, and malig-
nancy; and were not using anti-inflammatory drugs for 3
months before enrollment. Of the 184 dialysis patients
who were enrolled, there were 88 CAPD patients and 96
HD patients. Among the dialysis cohort, 22 patients were
diabetics. The CAPD patients underwent dialysis with
commercially available dialysate (Dianeal PD solution;
Baxter, Singapore) containing 40 mmol/L lactate (pH
5.2). The HD patients underwent HD 3 times a week with
the same type of HD membrane for more than 3 months.
A modified cellulose membrane (Toray, Tokyo, Japan) or
a synthetic membrane (polysulfone; Fresenius, Borken-
berg, Germany) was used. The dialysate was bicarbonate-
based and dextrose-free with 2.0 mEq/L potassium, 140
mEq/L sodium, and 3.0 mEq/L calcium. Dialysate and
blood flow rates were 500 mL/min and 250-300 mL/min,
respectively. We also selected 213 age-matched healthy
subjects from the health center at our hospital. This con-
trol group had normal renal function defined by a creati-
nine clearance of >100 mL/min. Healthy subjects with
systemic diseases, such as diabetes mellitus, renal disease,
hepatic disease, cardiac disease, and hypertension were
excluded.
Venous blood samples of all subjects were obtained after
they had fasted for at least 8 h. Blood samples were proc-
essed immediately. Levels of serum albumin, glucose,
total cholesterol, triglyceride, and electrolytes were meas-
ured with an autoanalyzer using commercial kits (Hitachi
7600.210; Hitachi Ltd., Tokyo, Japan). Biochemical data
were also obtained. Blood collected in tubes containing
ethylenediaminetetraacetic acid (EDTA) was centrifuged
at 1,500 g for 10 min at 4°C, and mtDNA was extracted
from peripheral leukocytes. The protocol was approved by
the Committee on Human Research at Chang Gung
Memorial Hospital-Kaohsiung Medical Center. Informed
consent was obtained from all participants.
Estimation of plasma free thiol content
Plasma-free thiol content was measured by directly react-
ing thiols with 5, 5-dithiobis 2-nitrobenzoic acid (DTNB),
whereby 5-thio-2-nitrobenzoic acid (TNB) was formed
[9]. Thiol content of the sample was calculated from the
absorbance by using the extinction coefficient of TNB
(A412 = 13,600 M-1·cm-1) [9].
Estimation of plasma content of thiobarbituric acid 
reactive substances)
The plasma content of thiobarbituric acid reactive sub-
stances (TBARS) was assessed by the method described by
Ohkawa et al. [10]. After centrifugation, plasma samples
were stored at -80°C for further analysis. The results were
expressed in terms of micromoles of TBARS per liter. A
standard curve of TBARS was obtained by hydrolysis of
1,1,3,3-tetraethoxypropane.
Determination of relative leukocyte mtDNA copy number
DNA purification
Blood was collected in EDTA (1 mg/ml)-containing tubes
from the peripheral vein. Buffy coat was separated from
blood samples by centrifugation for 10 min at 3,000 rpm.
The supernatant was carefully discarded by pipetting.
DNA was extracted using the Gentra® DNA extraction kit
(Qiagen, Germany).Journal of Negative Results in BioMedicine 2009, 8:10 http://www.jnrbm.com/content/8/1/10
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Determination of mtDNA content
For determination of mtDNA content relative to nuclear
DNA, the forward primer5'-GGCTCTGTGAGGGA-
TATAAAGACA-3' and reverse primer 5'-CAAACCAC
CCGAGCAACTAATCT-3' [complementary to sequences
of chromosome 1 (Chr1) genome loci on 1q24-25] were
used to amplify a 97-bp product.
For analysis of mtDNA, we used ND2 gene sequences, the
forward primer 5'-CACAGAAGCTGCCATCAAGTA-3' and
reverse primer 5'-CCGGAGAG TATATTGTTGAAGAG-3',
were amplified to obtain an 89-bp product. Polymerase
chain reaction (PCR) was performed in a Roche Lightcy-
cle® 480r (Roche Applied Sciences, Mannheim, Germany)
apparatus using the LightCycler® 480 SYBR Green I Master
Mix kit (Roche Applied Science). DNA (10 ng) was mixed
with 10 μl LightCycler® 480 SYBR Green I Master Mix con-
taining 5 μmol (final concentration 0.4 μM) of forward
and reverse primers in a final volume of 20 μl. PCR reac-
tions were conducted as follows: initially at 50°C for 2
min, 95°C for 1 min, 40 cycles for denaturation at 95°C
for 15 s, annealing at 60°C for 20 s, and primer extension
at 72°C for 15 s, and finally at 25°C. The threshold cycle
number (Ct) values of the Chr1 gene and ND2 gene were
determined for each individual quantitative PCR run. The
equation ΔCt [Ct (ND2)-Ct (Chr1)] represents the relative
abundance. The quantitative results were expressed as the
copy number of the mtDNA/cell by 2 × 2-ΔCt. Each meas-
urement was carried out at least 3 times and normalized
in each experiment against a serial dilution series of a con-
trol DNA sample.
Determination of D-loop sequence
The mtDNA control region segment (corresponding to
region 15911-602 in the Cambridge Reference Sequence)
was amplified using L15911 forward primer (5'-
ACCAGTCTTGTAAACCGGAG-3') and H602 reverse
primer (5'-GCTTTGAGGAGGTAAGCTAC-3'). The prod-
ucts were purified with the PCR Product Pre-Sequencing
Kit (GE Healthcare Life Sciences, Sweden) and sequenced
by using primer L15911 and primer L29 (5'-CTCACG-
GGAGCTCnTCCATGC-3') on an ABI 377XL DNA
sequencer (Applied Biosystems). However, because of the
frequent occurrence of poly-C at nucleotide pairs 16189
and 310 within the D-loop region, the sequencing proce-
dure ceased every time the samples harbored these vari-
ants. Reverse sequencing was then used with 2 additional
primers, namely, H81 (5'-CAGCGTCTCGCAATGCTATC-
3') and H602 (5'-GCTTTGAGGAGGTAAGCTAC-3'). DNA
sequences were analyzed by DNASTAR and BioEdit
sequencing alignment editor software (Copyright 1997-
2007 Tom Hall).
Statistical analysis
Statistical analysis was performed using the SPSS® version
12.0 software (SPSS Inc., Chicago, IL, USA). Before analy-
sis, all pre-exam data were fitted into a normal distribu-
tion. A two-tailed one-way analysis of variance (ANOVA)
was used to compare continuous variables between dialy-
sis patients and healthy subjects. The Mann-Whitney test
was applied to analyze categorical data and to compare
the difference in alterations of the D310 mononucleotide
repeat between dialysis and healthy control subjects. On
the basis of the least significant difference (LSD) method,
ANOVA with a post hoc test was used to examine differ-
ences in TBARS and free thiol contents and human leuko-
cyte mtDNA copy number among the 4 D310 repeat
groups (7-C, 8-C, 9-10C, and T-to-C transition) in dialysis
patients or control subjects. The level of significance was
set to P < 0.05. Values were expressed as means ± standard
deviation (SD).
Results
No significant differences were observed in age and gen-
der between dialysis patients and control subjects. Systolic
blood pressure of dialysis patients was higher than in con-
trol subjects, but this difference only reached marginal sta-
tistical significance. Diastolic blood pressure of dialysis
patients was lower than in control subjects. Comparison
of biochemical data revealed lower levels of albumin,
cholesterol, and sodium in dialysis patients as compared
to control subjects. Levels of oxidative stress variable
markers and levels of blood TBARS and mtDNA copy
number were higher in dialysis patients than in control
subjects, while blood free thiol levels were lower in dialy-
sis patients than in control subjects (Table 1).
Alterations in D310 mononucleotide repeat
In D310 mononucleotide repeat sequencing analysis, var-
iants can range at least from 7-C to 10-C among study sub-
jects. 7-C and 8-C were common D310 repeat alterations
in both dialysis patients and control subjects, and 8-C was
the most common in the control cohort. In contrast, 7-C
was the most common repeat alteration in the dialysis
patients. The distribution of 7-C, 8-C, and 9-10C in the
dialysis and control subjects was as follows: 7-C, 38% (n
= 70) vs. 31.5% (n = 67); 8-C, 35.3% (n = 65) vs. 43.2%
(n = 92); 9-10C, 24.5% (n = 45) vs. 22.1% (n = 47). T-to-
C transition was found in a few of the dialysis patients and
control subjects, 2.2% (n = 4) vs. 3.2% (n = 7) (Fig. 1).
Association of D310 mononucleotide repeat with oxidative 
stress biomarkers and mitochondrial DNA copy number
The study subjects were categorized into 4 subgroups
depending on D310 alterations, and significant differ-
ences were observed in the levels of oxidative stress
biomarkers and mtDNA copy number between dialysis
patients and control subjects in the 4 subgroups (Table 2).Journal of Negative Results in BioMedicine 2009, 8:10 http://www.jnrbm.com/content/8/1/10
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Analysis of variables by ANOVA, with the post hoc test
based on the LSD method, revealed that a difference in
D310 alterations (7-C to 10-C) did not result in a signifi-
cant difference in levels of oxidative stress biomarkers and
the mtDNA copy number in dialysis patients.
Discussion
An increased oxidative burden is observed in chronic
renal failure patients [1]. The onset of this condition is
during the pre-dialysis period, and it is particularly
remarkable after dialysis therapy is initiated [1,2]. Our
previous investigations showed that CAPD patients have
higher oxidative stress than healthy subjects, and this ele-
vated oxidative stress leads to alterations in the mtDNA
copy number in peripheral leukocytes [2]. In the present
study, we demonstrated that dialysis patients, either on
CAPD or HD, have increased blood levels of oxidative
stress biomarkers and an increased mtDNA copy number
in peripheral leukocytes. Since mitochondria are a major
source of ROS and are highly susceptible to oxidative
damage, we intend to further investigate the possible link
between oxidative stress and mtDNA mutations.
mtDNA deletions/insertions and base changes mainly
involve purine transitions, which have been assumed to
occur after the action of ROS [11]. Many common poly-
morphisms in mtDNA accumulate in the D-loop [12]. The
D-loop functions as a promoter for both heavy and light
strands of mtDNA. A mononucleotide repeat between
nucleotides 303 and 316-318 (D310) has recently been
identified as a frequent hotspot for mutations in primary
tumors [3]. Exposure to the oxidant tert-butyl hydroperox-
ide has been shown to induce mutations in the D310
region; this finding may explain the high frequency of
homoplasmic D310 somatic mutations in many types of
tumors [13]. The number of cytosines in the first stretch of
the D310 region can vary from 7 to 9 in normal individu-
als. The homopolymeric C-stretch is part of CSBII, located
within the regulatory D-loop region, and it is involved in
the formation of a persistent RNA-DNA hybrid that leads
to the initiation of mtDNA heavy-strand replication [14].
It is generally accepted that mtDNA mutations are gener-
ated during oxidative phosphorylation through pathways
involving ROS. We therefore hypothesized that mtDNA
mutations in the D-310 region would be frequently
detected in chronic renal failure patients. Further, we
expected somatic mutations in the D-310 region to be
associated with a change in the mtDNA copy number of
these patients.
Table 1: Characteristics of demographic, biochemistry, and oxidative stress marker variables in dialysis and healthy subjects
Dialysis patients Control group
N = 184 N = 213 P-value
Age 48.3 ± 14.2 49.2 ± 13.6 0.495
Gender (male) 71 83 0.938
BMI 22.1 ± 3.4 23.8 ± 3.7 0.000
Systolic BP (mmHg) 134 ± 25 130 ± 20 0.058
Diastolic BP (mmHg) 77 ± 14 82 ± 12 0.000
TBARS (μM/L) 1.126 ± 0.628 0.771 ± 0.478 0.000
Free thiol (μM/L) 1.515 ± 0.457 2.110 ± 0.423 0.000
mtDNA copy number 1664 ± 2551 412 ± 270 0.000
Hemoglobin (g/dl) 10.2 ± 1.7 14.0 ± 1.5 0.000
Hematocrit (%) 31.1 ± 5.4 42.2 ± 4.0 0.000
BUN (mg/dl) 68.6 ± 18.1 13.9 ± 4.2 0.000
Creatinine (mg/dl) 12.5 ± 2.7 1.0 ± 0.2 0.000
Sodium (mEq/L) 137 ± 4 141 ± 2 0.000
Potassium (mEq/L) 4.4 ± 0.8 4.2 ± 0.3 0.001
Calcium (mg/dl) 9.3 ± 1.0 9.1 ± 0.4 0.006
Phosphate (mg/dl) 5.1 ± 1.5 3.5 ± 0.5 0.000
Albumin (g/dl) 3.8 ± 0.4 4.3 ± 0.3 0.000
Blood sugar (mg/dl) 113 ± 47 101 ± 33 0.004
Total cholesterol (mg/dl) 190 ± 34 200 ± 37 0.006
Triglyceride (mg/dl) 162 ± 127 132 ± 133 0.018
Data presented as means ± standard deviation (SD) or (%). The Mann-Whitney test was used for ANOVA to compare groups (p < 0.05). TBARS, 
thiobarbituric acid reactive substances; mtDNA, mitochondrial DNA.
Comparison demographic, biochemistry, oxidative stress markers
variables in dialysis and healthy subjects. Lower levels of albumin, cholesterol, and sodium in the dialysis patients as compared to the control 
subjects. The levels of oxidative stress variables markers and levels of blood TBARS and mtDNA copy numbers were higher in the dialysis patients 
than in the control subjects, while the blood free thiol levels were lower in the dialysis patients than the control subjectsJournal of Negative Results in BioMedicine 2009, 8:10 http://www.jnrbm.com/content/8/1/10
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In the present study, we found that 7-C and 8-C were com-
mon variants in D-310 repeat in both the dialysis patients
and healthy subjects. This finding was identical to consti-
tutive polymorphisms, described in a previous study on
tumors [3]. Although the mtDNA copy number was
higher in the dialysis patients than in the control subjects,
a significant association between D-310 repeat alterations
and mtDNA copy number was not observed in dialysis
patients. Previous investigations have well established
that somatic mtDNA mutations accumulate with age;
however, the levels of any single mtDNA mutation are too
low to cause significant tissue pathology [15]. We pro-
posed that chronic renal failure was not the result of just
1 type of mtDNA damage but rather the sum total of a
large number of mtDNA mutations that accumulate con-
currently over time. This assumption may explain our
findings on the association between the mtDNA copy
number and D-310 repeat alterations.
Conclusion
In conclusion, dialysis patients had more oxidative stress
than healthy subjects. Although oxidative stress led to a
compensatory increase in the mtDNA copy number in
dialysis patients, alterations of D-310 repeat were not
associated with the mtDNA copy number. Finally, D-310
repeat alterations were not significantly different between
Comparison of difference in alterations in D310 mononucleotide repeat between dialysis and healthy control subjects Figure 1
Comparison of difference in alterations in D310 mononucleotide repeat between dialysis and healthy control 
subjects. *Mann-Whitney test. T to C: T-to-C transition.Journal of Negative Results in BioMedicine 2009, 8:10 http://www.jnrbm.com/content/8/1/10
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dialysis patients and healthy subjects. On the basis of our
findings, we have proposed a possible gateway to further
investigate the association between mtDNA mutations
and oxidative stress in chronic renal failure.
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